BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27671059)

  • 1. Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action.
    Cappiello F; Di Grazia A; Segev-Zarko LA; Scali S; Ferrera L; Galietta L; Pini A; Shai Y; Di YP; Mangoni ML
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7252-7262. PubMed ID: 27671059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo therapeutic efficacy of frog skin-derived peptides against Pseudomonas aeruginosa-induced pulmonary infection.
    Chen C; Mangoni ML; Di YP
    Sci Rep; 2017 Aug; 7(1):8548. PubMed ID: 28819175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane perturbing activities and structural properties of the frog-skin derived peptide Esculentin-1a(1-21)NH
    Loffredo MR; Ghosh A; Harmouche N; Casciaro B; Luca V; Bortolotti A; Cappiello F; Stella L; Bhunia A; Bechinger B; Mangoni ML
    Biochim Biophys Acta Biomembr; 2017 Dec; 1859(12):2327-2339. PubMed ID: 28912103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esculentin-1a Derived Antipseudomonal Peptides: Limited Induction of Resistance and Synergy with Aztreonam.
    Casciaro B; Loffredo MR; Luca V; Verrusio W; Cacciafesta M; Mangoni ML
    Protein Pept Lett; 2018; 25(12):1155-1162. PubMed ID: 30381056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(lactide- co-glycolide) Nanoparticles for Prolonged Therapeutic Efficacy of Esculentin-1a-Derived Antimicrobial Peptides against Pseudomonas aeruginosa Lung Infection: in Vitro and in Vivo Studies.
    Casciaro B; d'Angelo I; Zhang X; Loffredo MR; Conte G; Cappiello F; Quaglia F; Di YP; Ungaro F; Mangoni ML
    Biomacromolecules; 2019 May; 20(5):1876-1888. PubMed ID: 31013061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gold-nanoparticles coated with the antimicrobial peptide esculentin-1a(1-21)NH
    Casciaro B; Moros M; Rivera-Fernández S; Bellelli A; de la Fuente JM; Mangoni ML
    Acta Biomater; 2017 Jan; 47():170-181. PubMed ID: 27693686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-Amino acids incorporation in the frog skin-derived peptide esculentin-1a(1-21)NH2 is beneficial for its multiple functions.
    Di Grazia A; Cappiello F; Cohen H; Casciaro B; Luca V; Pini A; Di YP; Shai Y; Mangoni ML
    Amino Acids; 2015 Dec; 47(12):2505-19. PubMed ID: 26162435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Overview of Frog Skin-Derived Esc Peptides: Promising Multifunctional Weapons against
    Mangoni ML; Loffredo MR; Casciaro B; Ferrera L; Cappiello F
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells.
    Darling KE; Dewar A; Evans TJ
    Cell Microbiol; 2004 Jun; 6(6):521-33. PubMed ID: 15104594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esc peptides as novel potentiators of defective cystic fibrosis transmembrane conductance regulator: an unprecedented property of antimicrobial peptides.
    Ferrera L; Cappiello F; Loffredo MR; Puglisi E; Casciaro B; Botta B; Galietta LJV; Mori M; Mangoni ML
    Cell Mol Life Sci; 2021 Dec; 79(1):67. PubMed ID: 34971429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipseudomonal and Immunomodulatory Properties of Esc Peptides: Promising Features for Treatment of Chronic Infectious Diseases and Inflammation.
    Cappiello F; Carnicelli V; Casciaro B; Mangoni ML
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchial epithelium repair by Esculentin-1a-derived antimicrobial peptides: involvement of metalloproteinase-9 and interleukin-8, and evaluation of peptides' immunogenicity.
    Cappiello F; Ranieri D; Carnicelli V; Casciaro B; Chen HT; Ferrera L; Di YP; Mangoni ML
    Sci Rep; 2019 Dec; 9(1):18988. PubMed ID: 31831857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fighting microbial infections: A lesson from amphibian skin-derived esculentin-1 peptides.
    Mangoni ML; Luca V; McDermott AM
    Peptides; 2015 Sep; 71():286-95. PubMed ID: 25959536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DeltaF508-CFTR mutation results in increased biofilm formation by Pseudomonas aeruginosa by increasing iron availability.
    Moreau-Marquis S; Bomberger JM; Anderson GG; Swiatecka-Urban A; Ye S; O'Toole GA; Stanton BA
    Am J Physiol Lung Cell Mol Physiol; 2008 Jul; 295(1):L25-37. PubMed ID: 18359885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial and anti-inflammatory activity of a temporin B peptide analogue on an in vitro model of cystic fibrosis.
    Bezzerri V; Avitabile C; Dechecchi MC; Lampronti I; Borgatti M; Montagner G; Cabrini G; Gambari R; Romanelli A
    J Pept Sci; 2014 Oct; 20(10):822-30. PubMed ID: 25201563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Aib residues insertion on the structural-functional properties of the frog skin-derived peptide esculentin-1a(1-21)NH
    Biondi B; Casciaro B; Di Grazia A; Cappiello F; Luca V; Crisma M; Mangoni ML
    Amino Acids; 2017 Jan; 49(1):139-150. PubMed ID: 27726008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo.
    Uccelletti D; Zanni E; Marcellini L; Palleschi C; Barra D; Mangoni ML
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3853-60. PubMed ID: 20606068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deleterious impact of Pseudomonas aeruginosa on cystic fibrosis transmembrane conductance regulator function and rescue in airway epithelial cells.
    Trinh NT; Bilodeau C; Maillé É; Ruffin M; Quintal MC; Desrosiers MY; Rousseau S; Brochiero E
    Eur Respir J; 2015 Jun; 45(6):1590-602. PubMed ID: 25792634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic cystic fibrosis mice exhibit reduced early clearance of Pseudomonas aeruginosa from the respiratory tract.
    Schroeder TH; Reiniger N; Meluleni G; Grout M; Coleman FT; Pier GB
    J Immunol; 2001 Jun; 166(12):7410-8. PubMed ID: 11390493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
    Chen C; Deslouches B; Montelaro RC; Di YP
    Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.